Findex

Findex CROIC

The Cash Return on Invested Capital (CROIC) of Findex (3649.T) as of Oct 29, 2026 is 29.69 %. In the previous year, Cash Return on Invested Capital (CROIC) was 33.34 % — a change of -10.93% (lower).

CROIC

29.69 %

YoY

-10.93%

Last updated:

Cash Return on Invested Capital (CROIC) of Findex is 2025 29.69 % . Cash Return on Invested Capital (CROIC) of Findex was 2024 33.34 % . It decreases by -10.93% lower compared to the previous year.

The Findex CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
22.50 JPY
Jan 1, 2019
45.68 JPY
Jan 1, 2020
9.15 JPY
Jan 1, 2021
13.63 JPY
Jan 1, 2022
9.28 JPY
Jan 1, 2023
10.83 JPY
Jan 1, 2024
33.34 JPY
Jan 1, 2025
29.69 JPY
The Findex CROIC history
YEARCROICYoY
29.69 %-10.93%
33.34 %+207.85%
10.83 %+16.75%
9.28 %-31.94%
13.63 %+48.97%
9.15 %-79.97%
45.68 %+103.04%
22.50 %+16.69%
19.28 %-54.80%
42.66 %+890.93%
4.30 %-92.08%
54.37 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Findex Stock analysis

What does Findex do? FINDEX, Inc. generates revenue through its System Development segment, which offers medical system development, medical data integration and analysis, and office systems development. The Health Tech segment provides medical consulting, management consulting, healthcare data science, and AI services. Hospitals and clinics purchase the company's solutions for improving information management efficiency and enhancing medical practice quality. The System Development segment focuses on medical information systems, medical systems, and medical network systems that reduce administrative burdens for medical institutions. The company's products are tailored for hospitals and clinics, addressing their needs in medical information management and operational efficiency. The System Development segment emphasizes solutions that contribute to all patients by streamlining information management processes. The Health Tech segment leverages data science and AI to support healthcare consulting and management consulting services for medical institutions. FINDEX, Inc. serves medical institutions through two distinct business segments. The System Development segment develops systems that improve medical institution management and the quality of medical practice. The Health Tech segment integrates data science and AI into healthcare consulting and management consulting, targeting institutions seeking advanced data-driven solutions for operational improvements. Findex is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Findex stock

Cash Return on Invested Capital (CROIC) of Findex is 29.69 % in 2025.

Cash Return on Invested Capital (CROIC) of Findex changed from 33.34 % to 29.69 %, representing a -10.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Findex since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Findex with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Findex

All Key Metrics — Findex